Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1987 Nov;70(2):463–470.

In vitro analysis of B lymphocyte function in uraemia.

D Degiannis 1, A M Mowat 1, E Galloway 1, D Tsakiris 1, J D Briggs 1, B J Junor 1, D M Parrott 1
PMCID: PMC1542087  PMID: 3322618

Abstract

We have investigated the immune responses in vitro of uraemic patients undergoing regular haemodialysis or continuous ambulatory peritoneal dialysis. Twenty-five healthy subjects were also studied as controls. In uraemic patients, the number of T and B lymphocytes were within the normal range, but proliferative responses to phytohaemagglutinin (PHA) were impaired. Spontaneous immunoglobulin plaque forming cell (PFC) responses by peripheral blood mononuclear cells (PBMC) from uraemic patients were significantly lower than those of healthy subjects. The PFC response of uraemic PBMC to the T cell independent polyclonal B cell activator (PBA) Epstein-Barr virus (EBV) was comparable to the response of the healthy subjects, indicating that uraemic B cells are still capable of synthesizing immunoglobulin. Pokeweed mitogen (PWM) induced PFC responses of uraemic PBMC were also normal, whereas the response to another T cell dependent B cell activator, Staphylococcus aureus Cowan I (SAC), was very low. Addition of indomethacin to PWM- and SAC-activated cultures of uraemic PBMC enhanced the PFC response to SAC, but had little effect on the PWM response. As full differentiation of B cells in response to SAC depends on helper T cells, we conclude that a defect in T lymphocyte function accounts for the reduced spontaneous and SAC induced production of immunoglobulin by uraemic PBMC. This defect may be mediated by an indomethacin-sensitive mechanism.

Full text

PDF
463

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alevy Y. G., Slavin R. G., Hutcheson P. Immune response in experimentally induced uremia. I. Suppression of mitogen responses by adherent cells in chronic uremia. Clin Immunol Immunopathol. 1981 Apr;19(1):8–18. doi: 10.1016/0090-1229(81)90043-x. [DOI] [PubMed] [Google Scholar]
  2. Alevy Y. G., Slavin R. G. Immune response in experimentally induced uremia. II. Suppression of PHA response in uremia is mediated by an adherent, Ia-negative and indomethacin-insensitive suppressor cell. J Immunol. 1981 May;126(5):2007–2010. [PubMed] [Google Scholar]
  3. Bender B. S., Curtis J. L., Nagel J. E., Chrest F. J., Kraus E. S., Briefel G. R., Adler W. H. Analysis of immune status of hemodialyzed adults: association with prior transfusions. Kidney Int. 1984 Oct;26(4):436–443. doi: 10.1038/ki.1984.193. [DOI] [PubMed] [Google Scholar]
  4. Bird A. G., Britton S. A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator. Immunol Rev. 1979;45:41–67. doi: 10.1111/j.1600-065x.1979.tb00272.x. [DOI] [PubMed] [Google Scholar]
  5. Boulton-Jones J. M., Vick R., Cameron J. S., Black P. J. Immune responses in uremia. Clin Nephrol. 1973 Nov-Dec;1(6):351–360. [PubMed] [Google Scholar]
  6. Falkoff R. J., Zhu L. P., Fauci A. S. Separate signals for human B cell proliferation and differentiation in response to Staphylococcus aureus: evidence for a two-signal model of B cell activation. J Immunol. 1982 Jul;129(1):97–102. [PubMed] [Google Scholar]
  7. Forsgren A., Svedjelund A., Wigzell H. Lymphocyte stimulation by protein A of Staphylococcus aureus. Eur J Immunol. 1976 Mar;6(3):207–213. doi: 10.1002/eji.1830060312. [DOI] [PubMed] [Google Scholar]
  8. Greaves M., Janossy G. Elicitation of selective T and B lymphocyte responses by cell surface binding ligands. Transplant Rev. 1972;11:87–130. doi: 10.1111/j.1600-065x.1972.tb00047.x. [DOI] [PubMed] [Google Scholar]
  9. Gronowicz E., Coutinho A., Melchers F. A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol. 1976 Aug;6(8):588–590. doi: 10.1002/eji.1830060812. [DOI] [PubMed] [Google Scholar]
  10. Holdsworth S. R., Fitzgerald M. G., Hosking C. S., Atkins R. C. The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis. Clin Exp Immunol. 1978 Jul;33(1):95–101. [PMC free article] [PubMed] [Google Scholar]
  11. Huber H., Pastner D., Dittrich P., Braunsteiner H. In vitro reactivity of human lymphocytes in uraemia--a comparison with the impairment of delayed hypersensitivity. Clin Exp Immunol. 1969 Jul;5(1):75–82. [PMC free article] [PubMed] [Google Scholar]
  12. Kauffman C. A., Manzler A. D., Phair J. P. Cell-mediated immunity in patients on long-term haemodialysis. Clin Exp Immunol. 1975 Oct;22(1):54–61. [PMC free article] [PubMed] [Google Scholar]
  13. Keightley R. G., Cooper M. D., Lawton A. R. The T cell dependence of B cell differentiation induced by pokeweed mitogen. J Immunol. 1976 Nov;117(5 Pt 1):1538–1544. [PubMed] [Google Scholar]
  14. Kunori T., Fehrman I., Ringdén O., Möller E. In vitro characterization of immunological responsiveness of uremic patients. Nephron. 1980;26(5):234–239. doi: 10.1159/000181991. [DOI] [PubMed] [Google Scholar]
  15. Langhoff E., Ladefoged J. Cellular immunity in renal failure: depression of lymphocyte transformation by uraemia and methylprednisolone. Intra-individual consistency of lymphocyte responses to the in vitro suppressive effect of steroid. Int Arch Allergy Appl Immunol. 1984;74(3):241–245. doi: 10.1159/000233551. [DOI] [PubMed] [Google Scholar]
  16. Lortan J. E., Kiepiela P., Coovadia H. M., Seedat Y. K. Suppressor cells assayed by numerical and functional tests in chronic renal failure. Kidney Int. 1982 Aug;22(2):192–197. doi: 10.1038/ki.1982.152. [DOI] [PubMed] [Google Scholar]
  17. Matas A. J., Simmons R. L., Kjellstrand C. M., Buselmeier T. J., Najarian J. S. Increased incidence of malignancy during chronic renal failure. Lancet. 1975 Apr 19;1(7912):883–886. doi: 10.1016/s0140-6736(75)91684-0. [DOI] [PubMed] [Google Scholar]
  18. Merrill J. P. The immunologic capability of uremic patients. Cancer Res. 1968 Jul;28(7):1449–1451. [PubMed] [Google Scholar]
  19. Mingari M. C., Gerosa F., Carra G., Accolla R. S., Moretta A., Zubler R. H., Waldmann T. A., Moretta L. Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature. 1984 Dec 13;312(5995):641–643. doi: 10.1038/312641a0. [DOI] [PubMed] [Google Scholar]
  20. Muraguchi A., Kehrl J. H., Longo D. L., Volkman D. J., Smith K. A., Fauci A. S. Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function. J Exp Med. 1985 Jan 1;161(1):181–197. doi: 10.1084/jem.161.1.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pryjma J., Muñoz J., Galbraith R. M., Fudenberg H. H., Virella G. Induction and suppression of immunoglobulin synthesis in cultures of human lymphocytes: effects of pokeweed mitogen and Staphylococcus aureus Cowan I. J Immunol. 1980 Feb;124(2):656–661. [PubMed] [Google Scholar]
  22. Rappaport R. S., Dodge G. R. Prostaglandin E inhibits the production of human interleukin 2. J Exp Med. 1982 Mar 1;155(3):943–948. doi: 10.1084/jem.155.3.943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Raska K., Jr, Raskova J., Shea S. M., Frankel R. M., Wood R. H., Lifter J., Ghobrial I., Eisinger R. P., Homer L. T cell subsets and cellular immunity in end-stage renal disease. Am J Med. 1983 Nov;75(5):734–740. doi: 10.1016/0002-9343(83)90401-1. [DOI] [PubMed] [Google Scholar]
  24. Raskova J., Ghobrial I., Shea S. M., Eisinger R. P., Raska K., Jr Suppressor cells in end-stage renal disease. Functional assays and monoclonal antibody analysis. Am J Med. 1984 May;76(5):847–853. doi: 10.1016/0002-9343(84)90996-3. [DOI] [PubMed] [Google Scholar]
  25. Satomi S., Tanimura S., Kunori T., Taguchi Y., Kasai M. Monitoring of B lymphocyte response with the protein-A plaque assay in kidney transplant patients. Transplantation. 1983 Apr;35(4):324–328. doi: 10.1097/00007890-198304000-00012. [DOI] [PubMed] [Google Scholar]
  26. Thompson P. A., Jelinek D. F., Lipsky P. E. Regulation of human B cell proliferation by prostaglandin E2. J Immunol. 1984 Nov;133(5):2446–2453. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES